BL Pharmtech Corp. (KOSDAQ:065170)

BL Pharmtech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	25,905	20,819	44,929	55,605	116,549	145,716
Market Cap Growth	50.09%	-53.66%	-19.20%	-52.29%	-20.02%	65.77%
Enterprise Value	28,835	25,570	86,785	100,284	144,445	185,313
Last Close Price	971.00	780.00	1683.33	2083.33	4366.67	5583.33
PS Ratio	3.71	2.36	1.83	2.47	1.38	2.22
PB Ratio	1.19	0.86	1.41	1.35	1.78	2.00
P/TBV Ratio	1.20	0.87	1.46	2.26	2.66	4.13
P/FCF Ratio	22.24	-	5.85	-	46.44	-
P/OCF Ratio	22.24	-	5.62	-	37.64	25.11
EV/Sales Ratio	4.13	2.90	3.54	4.45	1.71	2.82
EV/EBITDA Ratio	-	-	-	-	-	394.74
EV/FCF Ratio	24.76	-	11.30	-	57.56	-
Debt / Equity Ratio	0.24	0.25	0.13	1.04	0.64	0.60
Debt / EBITDA Ratio	-	-	-	-	-	93.61
Debt / FCF Ratio	4.42	-	0.56	-	16.69	-
Asset Turnover	0.19	0.22	0.33	0.19	0.64	0.59
Inventory Turnover	2.46	1.64	1.32	0.87	6.68	5.12
Quick Ratio	0.32	0.73	1.79	0.34	0.90	0.71
Current Ratio	0.60	1.05	2.12	0.67	1.14	1.09
Return on Equity (ROE)	-24.23%	-20.39%	-37.90%	-27.09%	-29.05%	-26.79%
Return on Assets (ROA)	-7.44%	-6.68%	-5.99%	-2.56%	-1.70%	-1.15%
Return on Invested Capital (ROIC)	-17.47%	-17.60%	-14.08%	-5.88%	-3.80%	-2.64%
Return on Capital Employed (ROCE)	-18.80%	-14.60%	-19.30%	-8.80%	-3.90%	-2.00%
Earnings Yield	-23.23%	-27.41%	-0.33%	-25.00%	-17.34%	-12.32%
FCF Yield	4.50%	-20.19%	17.09%	-22.85%	2.15%	-8.11%
Buyback Yield / Dilution	0.43%	-	0.00%	-1.33%	-18.44%	-19.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.